Jake Morgan
Profiles

Jake Roberts Morgan, PhD

Research Assistant Professor, Health Law, Policy & Management - Boston University School of Public Health

(617) 358-2047
jakem@bu.edu
Talbot
View Full Profile at BUMC

Biography

Jake Morgan, PhD, is a health services researcher specializing in using real-world data to inform evidence-based policy, update clinical guidelines, and improve patient access to and quality of care.

His work is focused on the opioid overdose epidemic and how to best support patients by promoting access and retention to medications for opioid use disorder. His work on the comparative effectiveness of medications for opioid use disorder has been cited in a call for research by the director of the National Institute on Drug Abuse Nora Volkow and he has a history of collaboration with Massachusetts Department of Public Health to evaluate and inform addiction treatment services. His work has consistently reinforced the importance of patient choice when it comes to treatment for opioid use disorder and has documented the effects of policies that usurp this choice through onerous requirements for treatment, restricting access to vulnerable populations such as individuals who are incarcerated, and cost-sharing schemes that disincentivize treatment. As an applied health economist with extensive experience in statistical, econometric, and simulation modeling approaches, Dr. Morgan frequently works alongside clinical researchers to highlight (and cost) the best treatment interventions for patients. He is currently involved with the Health Economics core of the The HEALing Communities Study; the Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND) study; the Researching Effective Strategies to Prevent Opioid Death (RESPOND) simulation model, and; The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV trial.

Dr. Morgan works closely with The Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) as a member of the Population Data and Modeling Core and is the primary representative for Boston University School of Public Health. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors to inform policy to improve care for individuals with substance use disorder, HIV, and HCV. To that end, CHERISH offers resources and consultations to support this type of research for trainees and investigators at any stage. Please see https://cherishresearch.org/ or contact Dr. Morgan to learn more.

Education

  • Boston University, PhD Field of Study: Health Services Research
  • Montana State University, MS Field of Study: Economics
  • Hillsdale College, BS Field of Study: Economics/Mathematics

Websites

Publications

  • Published on 9/11/2025

    Friedmann PD, Wilson D, Stopka TJ, Bernson D, Pivovarova E, Ferguson W, Hoskinson RA, Rottapel RE, Bovell-Ammon B, Gaba A, Morgan JR, Senst T, Hayes E, Evans EA. Medications for Opioid Use Disorder in County Jails - Outcomes after Release. N Engl J Med. 2025 Sep 11; 393(10):994-1003. PMID: 40929634.

     Read At: PubMed
  • Published on 8/12/2025

    Haukoos J, Rothman RE, Galbraith JW, Hopkins E, Hsieh YH, Lyle C, Gravitz S, Kamis KF, White DAE, Lyons MS, Gardner EM, Al-Tayyib AA, Sabel AL, Linas BP, Morgan JR, Wyles DL, Rowan SE. Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical Trial. JAMA. 2025 Aug 12; 334(6):497-507. PMID: 40632510.

     Read At: PubMed
  • Published on 7/9/2025

    Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785. PMID: 40684522.

     Read At: PubMed
  • Published on 7/7/2025

    Levengood TW, Shaw LC, Zang X, Schackman BR, Walley AY, Urquhart C, Green TC, Chatterjee A, Marshall BDL, Morgan JR. A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND). Drug Alcohol Depend. 2025 Sep 01; 274:112783. PMID: 40683013.

     Read At: PubMed
  • Published on 6/3/2025

    Morgan JR, Walley AY. You have to be alive to enjoy the porridge: The role of Goldilocks naloxone dosing in a world of hungry bears. Addiction. 2025 Jun 03. PMID: 40458977.

     Read At: PubMed
  • Published on 6/2/2025

    Zwick H, O'Dea R, Barocas JA, Flam-Ross JM, Chatterjee A, Walley AY, Harris RA, Schackman BR, White LF, Chrysanthopoulou SA, Assoumou SA, Murphy SM, Morgan JR, Baptiste D, Carroll M, Linas BP. Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids. JAMA Netw Open. 2025 Jun 02; 8(6):e2517095. PMID: 40577017.

     Read At: PubMed
  • Published on 5/10/2025

    Lee CS, Cordova-Ramos EG, Rohsenow DJ, Mueser KT, Pace CA, Martin R, Colby SM, Lopez V, Morris M, Morgan JR, Kriegsman A, Drainoni ML. Care management staff perspectives on stigma and barriers to substance use treatment experienced by latine adults who use substances. Drug Alcohol Depend Rep. 2025 Jun; 15:100342. PMID: 40495911.

     Read At: PubMed
  • Published on 5/1/2025

    Assoumou SA, Morgan JR. A Path Forward for Extended-Release Buprenorphine-Optimizing Implementation Strategies. JAMA Netw Open. 2025 May 01; 8(5):e2513010. PMID: 40445626.

     Read At: PubMed
  • Published on 11/1/2024

    Fry CE, Jeffery AD, Horta M, Li Y, Osmundson SS, Phillippi J, Schirle L, Morgan JR, Leech AA. Changes in Postpartum Opioid Prescribing After Implementation of State Opioid Prescribing Limits. JAMA Health Forum. 2024 Nov 01; 5(11):e244216. PMID: 39602107.

     Read At: PubMed
  • Published on 10/25/2024

    Zang X, Skinner A, Li Z, Shaw LC, Behrends CN, Chatterjee A, Jalali A, Jordan AE, Morgan JR, Nolen S, Schackman BR, Marshall BDL, Walley AY. Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States. Addiction. 2025 Feb; 120(2):316-326. PMID: 39450522.

     Read At: PubMed

View 71 more publications:View Full Profile at BUMC

News & In the Media

View all profiles